go to contents

Boehringer Ingelheim RCV GmbH

Back to list

Facts

Founded
1948
Staff
2411
Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
industrial processing

Profile

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

R&D:The aim of pharmaceutical research at Boehringer Ingelheim in Austria is the development of new cancer medicines that offer a clear advantage compared with standard therapies. A team of more than 360 international specialists work there on new ways of treating cancer patients. Our scientists analyze the causes of malignant tumors and develop innovative substances. Since 2013 we have already launched 2 new drugs for the treatment of lung cancer.

Production:Boehringer Ingelheim in Austria was a pioneer in biotechnology, who started more than 50 years ago with research in chicken interferon. This ground-breaking work led to a number of collaborations. Since 1995 we have been active additionally in contract manufacturing.

Services:Apart from its own products Boehringer Ingelheim has helped its customers to bring more than 35 molecules to the market. This has earned us a reputation as one of the most experienced and reliable contract manufacturing organizations in the world. Boehringer Ingelheim BioXcellence provides the entire production technology chain from DNA to fill and finish under one roof at our facilities in Vienna (Austria), Biberach (Germany), Fremont (USA) and Shanghai (China).

Sales/Distribution:Boehringer Ingelheim’s success is based on new, innovative prescription medicines to prevent strokes in patients with artrial fibrillation, for the treatment of COPD and asthma, diabetes or lung cancer, among other indication areas. In the field of animal health we concentrate on vaccines as well as other medicines to keep animal patients healthy.

Similar companies in RDM biotech/pharma

Sola Diagnostics GmbH

Organization type
RDM biotech/pharma
Region
Tyrol
Focus
bioinformatics
Details

Green River Polymers Forschungs- und Entwicklungs GmbH

Organization type
RDM biotech/pharma
Region
Tyrol
Focus
industrial processing
Details

f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Hermes Pharma Ges.m.b.H.

Organization type
RDM biotech/pharma
Region
Carinthia
Focus
human health
Details

Contact

Dr. Boehringer-Gasse 5-11
1120 Wien
Vienna

Contact: Matthias Sturm (Head of Communications)
Email: info@boehringer-ingelheim.at
Website